Brief: TransCode Therapeutics Reports Q3 Loss Per Share $0.20

Transcode Therapeutics

15/11/2021 21:19

Nov 15 (Reuters) - Transcode Therapeutics Inc  RNAZ.O :
    * TRANSCODE THERAPEUTICS REPORTS BUSINESS PROGRESS AND THIRD
QUARTER 2021 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.20
    * TRANSCODE THERAPEUTICS - EXPECTS CASH, EQUIVALENTS AS OF
SEPT
30, 2021, SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH YEAR-END
2022
    * EXPECTS THAT OPERATING LOSSES WILL INCREASE SUBSTANTIALLY
IN
FORESEEABLE FUTURE

Source text for Eikon:  ID:nBw9dRhk9a 
Further company coverage:  RNAZ.O 

 ((Reuters.Briefs@thomsonreuters.com;))